HDFC Mutual Fund Sells 2.005% Stake in Piramal Pharma

HDFC Mutual Fund has disclosed a decrease in its shareholding in Piramal Pharma Ltd. The aggregate holding of HDFC Mutual Fund schemes has reduced by 2.005%, bringing their total stake down to 7.015% as of July 14, 2026. This follows a previous disclosure on June 27, 2025, where their holding was reported at 9.034%. The change is in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The total paid-up equity share capital of Piramal Pharma has slightly increased.